89 related articles for article (PubMed ID: 9682005)
1. Regulatory role of T cells in a murine model of lymphoproliferative disease.
Raveche E; Fernandes H; Ong H; Peng B
Cell Immunol; 1998 Jul; 187(1):67-75. PubMed ID: 9682005
[TBL] [Abstract][Full Text] [Related]
2. A cultured malignant B-1 line serves as a model for Richter's syndrome.
Peng B; Sherr DH; Mahboudi F; Hardin J; Wu YH; Sharer L; Raveché ES
J Immunol; 1994 Aug; 153(4):1869-80. PubMed ID: 8046247
[TBL] [Abstract][Full Text] [Related]
3. Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells.
Luzina IG; Knitzer RH; Atamas SP; Gause WC; Papadimitriou JC; Sztein MB; Storrer CE; Handwerger BS
Arthritis Rheum; 1999 Mar; 42(3):561-8. PubMed ID: 10088780
[TBL] [Abstract][Full Text] [Related]
4. The NZB mouse as a model for chronic lymphocytic leukemia.
Phillips JA; Mehta K; Fernandez C; Raveché ES
Cancer Res; 1992 Jan; 52(2):437-43. PubMed ID: 1370214
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle effects of IL-10 on malignant B-1 cells.
Yen Chong S; Lin YC; Czarneski J; Zhang M; Coffman F; Kashanchi F; Raveche E
Genes Immun; 2001 Aug; 2(5):239-47. PubMed ID: 11528515
[TBL] [Abstract][Full Text] [Related]
7. Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL.
Ramachandra S; Metcalf RA; Fredrickson T; Marti GE; Raveche E
J Clin Invest; 1996 Oct; 98(8):1788-93. PubMed ID: 8878429
[TBL] [Abstract][Full Text] [Related]
8. Altered CD45 expression in malignant B-1 cells.
Dang AM; Phillips JA; Lin T; Raveche ES
Cell Immunol; 1996 May; 169(2):196-207. PubMed ID: 8620547
[TBL] [Abstract][Full Text] [Related]
9. Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma.
Czarneski J; Lin YC; Chong S; McCarthy B; Fernandes H; Parker G; Mansour A; Huppi K; Marti GE; Raveche E
Leukemia; 2004 Mar; 18(3):597-606. PubMed ID: 14712288
[TBL] [Abstract][Full Text] [Related]
10. In vivo effects of hyperdiploid Ly-1+ B cells of NZB origin.
Raveche ES; Lalor P; Stall A; Conroy J
J Immunol; 1988 Dec; 141(12):4133-9. PubMed ID: 3264305
[TBL] [Abstract][Full Text] [Related]
11. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
12. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
Shimoni A; Marcus H; Dekel B; Shkarchi R; Arditti F; Shvidel L; Shtalrid M; Bucher W; Canaan A; Ergas D; Berrebi A; Reisner Y
Cancer Res; 1999 Dec; 59(23):5968-74. PubMed ID: 10606243
[TBL] [Abstract][Full Text] [Related]
13. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression.
Wu HY; Monsonego A; Weiner HL
J Autoimmun; 2006 Mar; 26(2):116-26. PubMed ID: 16426816
[TBL] [Abstract][Full Text] [Related]
15. Leishmania amazonensis: participation of regulatory T and B cells in the in vitro priming (PIV) of CBA/J spleen cells susceptible response.
Veras PS; Welby-Borges M; de Santana CD; Nihei J; Cardillo F; de Freitas LA
Exp Parasitol; 2006 Jul; 113(3):201-5. PubMed ID: 16516200
[TBL] [Abstract][Full Text] [Related]
16. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
[TBL] [Abstract][Full Text] [Related]
17. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
18. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
19. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells.
Groux H; Cottrez F; Rouleau M; Mauze S; Antonenko S; Hurst S; McNeil T; Bigler M; Roncarolo MG; Coffman RL
J Immunol; 1999 Feb; 162(3):1723-9. PubMed ID: 9973435
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells.
Shin JY; Yoon IH; Kim JS; Kim B; Park CG
Cell Immunol; 2009; 256(1-2):72-8. PubMed ID: 19249018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
